Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Health Policy topic
No spam. Unsubscribe anytime.
House approves reforms to pain‑management clinic licensing and high‑risk prescriber review
Summary
Senate Bill 2279, which reforms pain clinic licensure and authorizes the Department of Health to identify and review high‑risk opioid prescribers, passed the House after sponsor testimony and lawmaker questions about on‑site medical director requirements.
The House passed Senate Bill 2279 on third and final consideration; the sponsor described the legislation as reforms to pain management clinic licensure designed to give the Department of Health authority to identify high‑risk prescribers and to conduct chart reviews and investigations.
"Senate Bill 2,279 reforms pain management clinic licensure laws. It authorizes the Department of Health to determine criteria to identify high risk prescribers of opioids and allows the department to conduct a chart review as well as investigations," Chairman Kumar said while explaining the bill. He added that criteria for high‑risk prescribers would be published online.
Representative Barrett questioned a change that reduces the on‑site time requirement for the medical director from 20% of weekly operating hours to 20% of quarterly hours. Chairman Kumar said the adjustment reflected limited availability of specialists and aimed to provide leeway while maintaining coverage and phone availability.
The Speaker declared the bill passed after committee amendments were considered and the final vote taken.
